Renaissance Technologies’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-64,400
| Closed | -$5.64M | – | 3357 |
|
|
2018
Q3 | $5.64M | Sell |
64,400
-311,000
| -83% | -$27.2M | 0.01% | 1726 |
|
|
2018
Q2 | $37M | Buy |
375,400
+140,000
| +59% | +$13.8M | 0.04% | 579 |
|
|
2018
Q1 | $28M | Buy |
235,400
+227,300
| +2,806% | +$27.1M | 0.03% | 746 |
|
|
2017
Q4 | $1.03M | Buy |
+8,100
| New | +$1.03M | ﹤0.01% | 2651 |
|
|
2017
Q2 | – | Sell |
-51,100
| Closed | -$2.62M | – | 3175 |
|
|
2017
Q1 | $2.62M | Buy |
+51,100
| New | +$2.62M | ﹤0.01% | 2094 |
|
|
2016
Q3 | – | Sell |
-18,673
| Closed | -$1.04M | – | 3305 |
|
|
2016
Q2 | $1.04M | Sell |
18,673
-195,327
| -91% | -$10.8M | ﹤0.01% | 2518 |
|
|
2016
Q1 | $13.4M | Buy |
+214,000
| New | +$13.4M | 0.03% | 929 |
|
|
2015
Q3 | – | Sell |
-102,399
| Closed | -$12.3M | – | 3143 |
|
|
2015
Q2 | $12.3M | Buy |
+102,399
| New | +$12.3M | 0.03% | 816 |
|
|
2014
Q2 | – | Sell |
-158,700
| Closed | -$10.7M | – | 2763 |
|
|
2014
Q1 | $10.7M | Buy |
+158,700
| New | +$10.7M | 0.03% | 827 |
|